Early relapse after thymectomy in myasthenia gravis
Part of Blood & lymphatic, Brain & nervous system, Cancer, Immune system & allergy clinical trials.
This study looks at how often myasthenia gravis symptoms return within six months after having the thymus gland removed (thymectomy), and what factors might predict that early return. The goal is to help doctors understand the disease better and improve future treatment planning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have a confirmed diagnosis of myasthenia gravis, which is a condition that causes muscle weakness.
- You must have had a thymectomy, which is surgery to remove the thymus gland in your chest.
- Your medical records before surgery must be complete and available for review.
- You must have a follow-up visit within six months after surgery to check your symptoms, unless a relapse happens earlier.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the thymus gland and certain antibodies relate to myasthenia gravis, a condition that causes muscle weakness. It may help doctors understand the disease better and could lead to improved treatments.
This trial tests the drug efgartigimod given before and after surgery for people with myasthenia gravis and a thymoma. The goal is to see if it helps improve symptoms and recovery around the operation.
This 10-year study collects information from people with myasthenia gravis to learn more about the condition and improve care. By sharing your experiences, you can help researchers understand what daily life is like and shape future treatments.
This trial looks at adding radiation after a complete surgery to remove a thymoma (a tumor from the thymus) at stages II or III. It may help lower the chance the cancer comes back by treating leftover microscopic disease after surgery.
This study uses wearable sensors to track symptoms of myasthenia gravis in daily life. The goal is to see if these devices can better monitor how the disease changes over time.
This trial tests if adding a steroid (methylprednisolone) to standard chemotherapy and radiation helps people with thymoma that cannot be fully removed by surgery or has come back. The goal is to see if this combination works better at controlling the disease.
Hear when a new Myasthenia Gravis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.